Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT07044401 · ClinicalTrials.gov registry record · Phase 1
A Single-dose Study to Investigate the Effect of Injection Site on KAI-9531 Relative Bioavailability in a Range of Body Mass Indices
A Phase 1 study, sponsored by Kailera.
- Completed
- Registry status
- Phase 1
- Development phase
- 51
- Enrollment target
NCT07044401 is a Phase 1 study that has completed, run by Kailera. The registered enrollment target is 51 participants.
The verdict
NCT07044401, a Phase 1 study, has completed, sponsored by Kailera.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 51 participants
- Enrollment target
Study Summary
The main objective of the study is to assess the relative bioavailability of KAI-9531 subcutaneous (SC) injection in the upper arm and thigh compared to the abdomen.
Interventions
- DRUG KAI-9531
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 51 participants |
| Start Date | 2025-07-14 |
| Est. Completion | 2025-11-13 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT07044401
The ClinicalTrials.gov registry entry for NCT07044401 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 51 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Kailera, which has 6 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which KAI-9531 is the first listed.
NCT07044401 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT07044401 about?
NCT07044401 is a clinical study titled "A Single-dose Study to Investigate the Effect of Injection Site on KAI-9531 Relative Bioavailability in a Range of Body Mass Indices". The main objective of the study is to assess the relative bioavailability of KAI-9531 subcutaneous (SC) injection in the upper arm and thigh compared to the abdomen.
What is the current status of trial NCT07044401?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 51 participants. The study started on 2025-07-14. Estimated completion is 2025-11-13.
What interventions are being tested in trial NCT07044401?
The interventions under investigation include: KAI-9531 (DRUG).
Who is sponsoring clinical trial NCT07044401?
This trial is sponsored by Kailera, which has 6 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.